Able Care Logo
PE Operators

Standardize your care portfolio. Unlock EBITDA growth across 8+ locations.

Portfolio-level visibility across clinical outcomes, financial performance, and operational metrics. Due diligence in days, not weeks.

Gentleman using the GripAble sensor in a studio portrait

The portfolio challenge

Portfolio Fragmentation

Every acquired site runs its own clinical processes. Screening protocols vary by location. Data formats differ. Aggregating outcomes across the portfolio requires manual effort that delays reporting and obscures performance gaps. Without standardization, you cannot benchmark one site against another.

EBITDA Realization Gap

Operational inconsistency erodes margin. When each location defines quality differently, cost structures diverge and best practices stay local. Falls-related hospitalizations, liability exposure, and staff turnover compound the gap between projected and realized EBITDA. Standardized screening protocols close that gap by reducing adverse events and creating a consistent cost baseline.

Due Diligence Friction

Prospective acquisitions require weeks of manual data collection to assess clinical quality. Without a unified data layer, due diligence teams cannot compare targets against existing portfolio benchmarks. Able Assess creates a standardized clinical dataset across every site, reducing diligence timelines and giving your investment committee objective quality metrics from day one.

What Able Assess delivers for PE operators

Unified Portfolio Visibility

One dashboard across every site. Compare clinical outcomes, screening volumes, and risk profiles at portfolio level. No manual aggregation.

Accelerated Integration Timeline

New acquisitions adopt the same screening protocol on day one. Staff are proficient in 15 minutes. No site-level customization required.

EBITDA Uplift Through Standardization

Reduce falls-related hospitalizations and liability exposure. Consistent protocols lower cost variance across sites and protect margin.

Investor-Ready Metrics

Clinical outcome data formatted for board reporting and investor updates. Objective evidence of operational quality that supports valuation.

What they say

What operators say

Portfolio standardization quote coming soon.

Questions from PE operators

Able Assess uses a specialized, clinical-grade dynamometer and an iPad or Android tablet. The hardware is provided as part of your subscription and comes pre-configured and ready to use.

Ready to standardize and unlock portfolio EBITDA?